T. Rowe Price Associates’s MediWound MDWD Stock Holding History

T. Rowe Price Associates’s Portfolio MDWD Stock Details MDWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.43M	Sell	641,075 -68,772	-10%	-$1.09M	﹤0.01%	1347
2026 Q1	$11.4M	Buy	709,847 +155,349	+28%	+$2.7M	﹤0.01%	1186
2025 Q4	$10.2M	Sell	554,498 -60,005	-10%	-$1.1M	﹤0.01%	1231
2025 Q3	$11.1M	Buy	614,503 +239,632	+64%	+$4.42M	﹤0.01%	1201
2025 Q2	$7.26M	Buy	374,871 +215,180	+135%	+$4.05M	﹤0.01%	1192
2025 Q1	$2.48M	Buy	+159,691	New	+$2.86M	﹤0.01%	1508
2014 Q4	–	Sell	-32,931	Closed	-$1.44M	–	2552
2014 Q3	$1.44M	Sell	32,931 -3,571	-10%	-$205K	﹤0.01%	1641
2014 Q2	$2.91M	Buy	+36,502	New	+$2.97M	﹤0.01%	1523

Other funds holding MDWD

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $527M AUM 50.16% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

T. Rowe Price Associates's MDWD Position: Q2 2026 in Review

T. Rowe Price Associates reduced its MediWound (MDWD) stake by 9.7% in Q2 2026, selling an estimated $1.09M and leaving 641,075 shares worth $9.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1347.

T. Rowe Price Associates first reported a position in MDWD in Q2 2014 and has held it in 8 quarters since. The position peaked at $11.4M in Q1 2026. 79 funds tracked by Wall St. Rank hold MDWD as of Q2 2026.

T. Rowe Price Associates held 641,075 shares of MediWound worth $9.43M as of Q2 2026.
T. Rowe Price Associates sold 68,772 MediWound shares in Q2 2026, an estimated $1.09M.
MediWound made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1347 holding.
T. Rowe Price Associates first reported a position in MediWound in Q2 2014 and has held it in 8 quarters since.
T. Rowe Price Associates's MediWound position peaked at $11.4M in Q1 2026.
79 funds tracked by Wall St. Rank held MediWound as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.